Page 1

( Mark One ) X UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON , DC 20549 ANNUAL REPORT UNDER SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31 , 2020 FORM 10 - K Title of each class TRANSITION REPORT UNDER SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from or Delaware ( State or other jurisdiction of incorporation or organization ) Common Stock , par value $ 0.0001 per share Commission file number 1-11388 VIVEVE MEDICAL , INC . ( Exact name of Registrant as specified in its charter ) .to VIVE 04-3153858 345 Inverness Drive South Building B , Suite 250 Englewood , CO 80112 ( Address of principal executive offices - Zip Code ) Registrant's telephone number , including area code : ( 720 ) -696-8100 Securities registered pursuant to Section 12 ( b ) of the Act : Trading Symbol ( I.R.S. Employer Identification No. ) Name of each exchange on which registered The Nasdaq Capital Market Securities registered pursuant to Section 12 ( g ) of the Act : None . Indicate by check mark if the Registrant is a well - known seasoned issuer as defined in Rule 405 of the Securities Act . Yes Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15 ( d ) of the Act . Yes X No | No Indicate by check mark whether the Registrant ( 1 ) has filed all reports required to be filed by Section 13 or 15 ( d ) of the Securities Exchange Act of 1934 during the preceding 12 months ( or for such shorter period that the Registrant was required to file such reports ) , and ( 2 ) has been subject to such filing requirements for the past 90 days . Yes No